Claims and lawsuits are being made after the manufacturer of Invokana never adequately warned doctors and patients of the harmful side effects associated with SGLT2 inhibitors such as
Invokana (canagliflozin) is a type-2 diabetes medication that helps control the blood sugar levels by forcing the removal of excess glucose through the urine. Originally approved in 2013, the medication proved to be more dangerous than expected when, in 2015 the U.S. Food and Drug Administration issued a new warning about harmful side effects. There was an increased risk for diabetic ketoacidosis (DKA). Other hazardous adverse reactions included severe kidney damage and failure.
Diabetic ketoacidosis signs and symptoms often develop quickly, sometimes within 24 hours. For some, these signs and symptoms may be the first indication of having diabetes. You may notice:
In fact our firm is currently helping those damaged by Invokana (canagliflozin.)
Call today 1-888-HDZLAW-8
921 N. Chaparral Suite 100 Corpus Christi, Texas 78401Phone: 361-792-3811